-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Guardant Health, Raises Price Target to $125

Benzinga·12/22/2025 12:50:09
語音播報
Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $100 to $125.